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Abstract 
 
The clinical need for vascular grafts is associated with cardiovascular diseases frequently leading 
to fatal outcomes. Artificial vessels based on bioresorbable polymers can replace the damaged 
vascular tissue or create a bypass path for blood flow while stimulating regeneration of a blood 
vessel in situ. However, the problem of proper conditions for the cells to grow on the vascular 
graft from the adventitia while maintaining its mechanical integrity of the luminal surface remains 
a challenge. In this work, we propose a two-stage technology for processing electrospun vascular 
graft from polycaprolactone, which consists of plasma treatment and subsequent immobilization 
of hyaluronic acid on its surface producing thin double-sided graft with one hydrophilic and one 
hydrophobic side. Plasma modification activates the polymer surfaces and produces a thin layer 
  
 
 
 
 
 
 
 
for linker-free immobilisation of bioactive molecules, thereby producing materials with unique 
properties. Proposed modification does not affect the morphology or mechanical properties of the 
graft and improves cell adhesion. The proposed approach can potentially be used for various 
biodegradable polymers such as polylactic acid, polyglycolide and their copolymers and blends, 
with a hydrophilic inner surface and a hydrophobic outer surface.  
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1. Introduction 
Cardiovascular disease (CVD) accounts for the death of more than 18 million people a year, with 
vascular atherosclerosis being the cause in ~ 65 % cases [1]. The situation is aggravated by another 
acute problem arising from congenital malformations of large vessels (stenosis and atresia), when 
arteries or veins are narrowed, overgrown or completely absent due to intrauterine developmental 
defects. In most of these cases, the only possible treatment is to bypass the blood flow or directly 
replace the damaged (narrowed) vascular tissue with an artificial implant. Nowadays, due to 
significant clinical limitations, the use of auto-, allo-, and xenografts, as well as grafts made of 
biostable polymers (Gortex®, Dacron®), is possible only for prosthetics of large-sized vessels 
[1,2].  
  
 
 
 
 
 
 
 
One of the promising strategies for solving the problem of graft deficiency is the development of 
artificial vessels based on bioresorbable polymers with an ability to stimulate regeneration of a 
blood vessel in situ [3]. Such vessels can be mass produced, ready to use, and could be easily 
commercialized. Due to their good physical and mechanical properties, high biocompatibility, low 
thrombogenesis and bioresorbability, electrospun artificial vessels made of polycaprolactone 
(PCL) are among the most promising. Among the other advantages of PCL are a lack of isomers, 
low melting point and good rheological and viscoelastic properties [4–6]. Despite the fact that 
elecrospun PCL scaffolds mimic the topology of extracellular matrix (ECM) and show good 
mechanical performance [7–9], they still suffer from high hydrophobicity which can affect cell 
adhesion [10,11]. Thus, the problem of proper conditions for the cells to grow on the inner volume 
of the vessel from the adventitia while maintaining its mechanical integrity of the luminal surface 
is one of the main challenges for vascular graft development [12].  
To address this problem, several basic strategies have been proposed, including pore size gradient 
of graft in the direction of luminal surface-adventitia [13]; incorporation of biologically active 
compounds into the bulk or surface of the graft-forming fibers [14]; grafts based on composite 
fibers [15,16], plasma treatment [17] and etc. Despite the significant results achieved recently of 
each of the above strategies, none of them can be considered perfect. The strategy of gradient 
porosity is faced with the need to increase the thickness of the graft wall to prevent the risk of 
aneurysms, while significant difference in the wall thickness of the prosthesis could lead to 
changes in mechanical properties and cause graft failure [18]. Introduction of biologically active 
substances into the polymer spinning solution lead to changes in the electrical and rheological 
properties, leading to the formation of defective fibers and decrease in the graft material strength. 
Plasma treatment alters the wettability and increases the surface free energy, however this effect 
lasts several weeks which makes it difficult to use this strategy to create commercially available 
grafts with a long shelf life [19]. Therefore, the development of effective strategies for creating 
vascular grafts is considered to be an urgent task and the success of modern vascular surgery 
largely depends on its solution [20]. 
In this work, we propose a two-stage technology for processing vascular graft from PCL, which 
consists of 1) plasma treatment in a reactive magnetron discharge with the sputtering of a titanium 
target in a nitrogen atmosphere and 2) subsequent immobilization of hyaluronic acid on its surface. 
Plasma treatment enables the formation of a gradient coating in the bulk of the porous graft 
material, characterized by a negative concentration gradient of ions of the sputtered target from 
the external to the internal surface of the graft, while maintaining the graft structural integrity and 
  
 
 
 
 
 
 
 
mechanical strength [11,21]. The choice of reactive magnetron sputtering of a titanium target in a 
nitrogen atmosphere for processing PCL graft is due to formation of thin films of titanium oxide 
doped with nitrogen (TiON) on the surface of polymer material [22]. Such coating are able to 
produce nitric oxide [23], which accelerates the endothelization process [24]. However, an 
interesting phenomenon occurring in many plasma operating methods is hydrophobic recovery (or 
aging), which manifests itself as a gradual increase in water contact angle towards its original value 
[19].  
Current strategies to reduce aging in plasma polymer film include enhancement of the degree of 
cross-linking, plasma coating architecture engineering, e.g. gradient structure and post-plasma 
grafting to decrease the number of reactive sites [25]. For most applications, especially biomedical, 
it is necessary to obtain a distinct number of functional groups. Therefore, plasma-based coatings 
with a vertical gradient structure have been proposed. 
To obtain stabilized hydrophilic surfaces, a vascular graft modified in a plasma of a reactive 
magnetron discharge was kept in an aqueous solution of hyaluronic acid (HA) due to its high 
biocompatibility [26], high ability to maintain proliferation and normal functional activity of 
endothelial cells [27] and aortic smooth muscle cells (SMC) [28]. 
Hence, proposed strategy makes it possible to obtain a polycaprolactone vascular graft with a 
stable superhydrophilic outer surface (from the adventitious side) while maintaining high 
hydrophobicity of its inner surface (luminal surface). 
 
2. Materials and Methods 
 
2.1 Production of PCL vascular graft 
To produce PCL vascular graft, 8% solution of PCL (80,000 g/mol, Sigma-Aldrich, UK) in 
trichloromethane (Fisher, UK) was prepared. The solution was stirred in a sealed glass reactor at 
30°C until a homogeneous state then cooled to room temperature and loaded into an ES apparatus 
(NANON-01A, MECC Co., Japan) with the following technological parameters: polymer-solution 
flow rate - 6 mL/hr, needle-to-collector distance - 190 mm and voltage - 20 kV. The thickness of 
the obtained electrospun material was 236 ± 10 µm. For most of studies to obtain flat samples 
electrosun grafts were cut longitudinally. 
 
2.2 DC Plasma Treatment  
  
 
 
 
 
 
 
 
Prior to modification, the electrospun PCL vascular grafts were placed in a vacuum at 10-2 Pa to 
remove the residual solvent. The scaffolds were modified by a DC magnetron sputtering technique. 
The metal target was a chemically pure (99.99%) titanium (Ti) placed under a nitrogen atmosphere 
(N2). The modification parameters were set as follows: the discharge power 20, 45, 75, 105, 135 
W), operating pressure in the chamber of 0.7 Pa (99.99% N2 gas), magnetron-to-target distance of 
40 mm, magnetron area of 240 cm2 and 4 min modification time. To avoid excessive rise of the 
sample temperature during the plasma treatment, the modification time was divided into one-
minute treatments, each separated by a one-minute cooldown period. The maximum chamber 
temperature during the whole process was 39°C. 
 
2.3 Immobilisation of HA 
The plasma-treated samples were placed in a 0.1 wt.% aqueous solution of HA (Mw = 2 × 106 
g/mol, Sinopharm Chemical Reagent Co., China) for 30 min. The samples were washed with 
distilled water and dried at room temperature. The designed HA concentration (0.1 wt.%) 
maximises the biocompatibility of the scaffolds without evoking an additional immune response 
[29]. 
 
2.4 Scanning Electron Microscopy (SEM) 
The morphology of the samples was investigated by SEM on an ESEM Quanta 400 FEG 
instrument (FEI, USA). Prior to the investigation, samples were coated with a thin gold layer by 
the magnetron sputtering system (SC7640, Quorum Technologies Ltd., UK). The fibre diameter 
was determined from SEM images captured in five fields of view using ImageJ 1.38 software 
(National Institutes of Health, USA). The average diameter was determined from at least 60 fibres.  
 
2.5 Contact-Angle Measurements 
The wettability of the samples was characterised by depositing 3 μL drops of polar liquid (water 
and glycerine) at different positions on the samples in a Krüss EasyDrop contact-angle 
measurement system and capturing the images one minute after depositing the drops. All data are 
represented as the averages and standard deviations of the measurements taken at five different 
spots on the surface of the respective sample.  
 
2.6 X-Ray Photoelectron Spectroscopy (XPS) 
  
 
 
 
 
 
 
 
XPS measurements were carried out in an Escalab 250Xi machine (Thermo Fisher Scientific Inc., 
UK) equipped with a monochromatic AlKα radiation source (photon energy: 1486.6 eV). The 
spectra were acquired in constant-pass energy mode at 100 eV for the survey spectrum and 50 eV 
for the element core-level spectrum. The spot size of the X-ray beam was 650 µm, and the total 
energy resolution was approximately 0.55 eV. Investigations were carried out at room temperature 
in an ultrahigh vacuum (with pressure of the order of 1 × 10−9 mbar; in the electron–ion 
compensation system, the Ar partial pressure was 1 × 10−7 mbar). The library of the reference XPS 
spectra, including the atomic registration sensitivity factors, was available in the Advantage Data 
System provided by the instrument manufacturer. The peaks were deconvoluted by Avantage 
software (Thermo Fisher Scientific Inc., UK) set to Shirley background subtraction followed by 
peak fitting to Voigt functions with an 80% Gaussian and 20% Lorentzian character. Each XPS 
experiment included 2 replicates. Each time, the measurements were done at least at 2 different 
locations. 
 
2.7 Mechanical Studies 
The mechanical properties of the samples were investigated by uniaxially stretching five pieces of 
each sample in a tensile testing machine (Instron 3369; Illinois Tool Works, USA) with a 50 N 
sensor. The traverse speed was set to 10 mm/min. 
 
2.8 Cell adhesion studies 
Given that the produced grafts had two different surfaces, the cell adhesion to each of them was 
studied. To do that, cells were separately cultured on the plasma-treated HA-coated side of the 
graft (further referenced as PCL-HA top) and the opposite, non-modified side of the graft (further 
referenced as PCL-HA bottom). Non-treated PCL graft samples were used as a control (Control 
samples).  
Cell adhesion was studied using human multipotent mesenchymal stem cells (MMSCs) harvested 
from subcutaneous adipose tissue of healthy donors. All experiments were performed according 
to the Declaration of Helsinki within an approval of Ethics Committee of the Almazov National 
Medical Research Centre (no. 12.26/2014; December 1, 2014). Written informed consent was 
obtained from all the subjects before the fat tissue biopsy. Adipose-derived human multipotent 
MSCs had the following phenotype: CD19-, CD34-, CD45-, CD73+, CD90+, CD105+, as 
confirmed by flow cytometry (GuavaEasyCyte8; MerckMillipore, Darmstadt, Germany) and 
monoclonal antibodies (Becton Dickinson, Franklin Lakes, NJ, USA). Cells were cultured in α-
  
 
 
 
 
 
 
 
MEM medium (PanEco, Moscow, Russia) supplemented with 10% fetal calf serum (HyClone 
Laboratories, Inc., Logan, UT, USA), 1% L-glutamine, and 1% penicillin/streptomycin solution 
(Invitrogen, Waltham, MA, USA) in 37°C and 5% CO2. Samples of the grafts were cut in 12 × 8 
mm pieces and placed in the wells of a 24-well plate. Cells were seeded on top of the scaffold at a 
density of 5 × 104 cells per well, and co-cultured with the material for 72 hours in above mentioned 
conditions. The experiment was performed in triplicates. After 72 hours, the samples were 
transferred to the new wells of the plate, washed in PBS and fixed in a 4% solution of 
paraformaldehyde (PFA) for 10 minutes. The cells adhered to the sample surface were 
permeabilized by 0.05% Triton X-100 followed by rinse with PBS, blocked with 10% goat serum 
solution in PBS for 30 minutes at room temperature and incubated with an anti-vinculin antibodies 
(Thermo Fisher Scientific, Waltham, MA, USA) at 1:200 dilution for one hour. After three PBS 
washes, the cells were incubated with AlexaFluor 568 goat anti-mouse IgG (H+L) anti-bodies 
(Invitrogen, Waltham, MA, USA) at 1:1000 dilution for one hour at room temperature in the dark. 
The cells were washed thrice with PBS (5 min each) and stained with 4’,6-diamidino-2-
phenylindole (DAPI) for visualization of the nuclei.  
For the quantitative and qualitative analysis, the adherent cells were imaged using Axiovert 
inverted fluorescence microscope (Zeiss, Germany) equipped with a Canon camera. Samples were 
placed between the two glass slides and ten different fields of view were captured at magnifications 
of ×10 and ×40 for each replicate. Quantitative analysis was performed by analysing images taken 
at a ×10 magnification (counting the nuclei of cells stained with DAPI), while qualitative analysis 
was performed using images taken at ×40 magnification (assessing the morphology of cells by 
stained cytoskeleton). 
 
2.9 Statistical Analysis 
Statistical analysis of physico-chemical data was performed in GraphPad Prism, version 8.00 for 
Windows (GraphPad Software, La Jolla California, USA) using Kruskal–Wallis test and Student’s 
t test. The data are shown as mean (SD) ± standard deviation (SD). Statistical analysis of biological 
data was performed using the non-parametric Mann-Whitney U test. The data are presented as 
arithmetic mean (Mean) ± standard error (SE). Differences were considered significant at the p < 
0.05 level. 
  
  
 
 
 
 
 
 
 
 
3. Results and Discussion 
SEM images of the PCL vascular grafts before and after plasma treatment are shown in Fig. 1.  
 
 
Fig. 1. SEM images of the electrospun PCL vascular grafts after plasma treatment at different 
currents: (a) untreated scaffolds and scaffolds treated at 20 W (b), 45 W(c), 75 W (d), 105 W (e) 
and 135 W (f). 
 
The untreated electrospun PCL vascular graft consists of randomly intertwined cylindrical fibres 
with an average diameter of 2.0 ± 0.4 μm (Fig. 1(a)). As the treatment current increased from 20 
to 45 A, the mean fibre diameter slightly decreased due to plasma etching and thermal impact. At 
a plasma treatment of 75 A, the fibres were melted in crossing areas and fibre surface was wrinkled. 
The formation of wrinkles and cracks on the fibre’s surface could be caused by the difference in 
the elasticity of the polymer base and thin TiON coating whose thickness increases with an 
increase of the treatment time. An increase of discharge power leads to the overall melting of the 
fibres (Fig. 1 e-f). 
  
 
 
 
 
 
 
 
The mechanical properties are essential for effective long-term implantation of tissue-engineered 
scaffolds. To evaluate plasma treated electrospun electrospun PCL vascular grafts, mechanical 
properties such as tensile strength, elongation and Young’s modulus was measured. Results of the 
investigation of electrospun electrospun PCL vascular grafts mechanical properties are presented 
in Table 1. 
 
Table 1. The mechanical properties of the electrospun PCL vascular grafts. 
Sample Tensile strength, МРа 
Young’s modulus, 
MPa 
Control 3.54 ± 0.15 7.79 ± 0.32 
20 W 3.39 ± 0.32 10.44 ± 0.52* 
45 W 4.02 ± 0.17 10.57 ± 0.35* 
PCL-HA 3.54 ± 0.30 10.83 ± 0.55* 
75 W 7.01 ± 0.23* 56.28 ± 17.07* 
105 W 13.55 ± 0.19* 159.14 ± 3.82* 
135W 19.63 ± 2.63* 171.42 ± 21.12* 
   
 
*p < 0.05 in comparison with control (Kruskal–Wallis test). 
 
As the current increased in the plasma treatment, Young’s modulus and tensile strength improved, 
especially in the 75-135W range. This trend can be attributed to thermal fibre bonding within the 
scaffold, which enhances the tensile properties of the electrospun PCL scaffolds by thermally 
induced shrinkage and molecular chain relaxation of the amorphous regions [7]. However, 
although the inter-fibre thermal bonding improved the mechanical stability of the electrospun 
scaffolds, it caused significant morphological changes (see Figs. 1(d)–1(f)). 
Lowering the discharge power of the DC magnetron sputtering and applying the HA treatment 
slightly enhanced Young’s modulus without changing the morphological properties (Figs. 1(a)–
1(c)).  
The effect of the plasma treatment and HA immobilisation on the wettability of the PCL nonwoven 
material was examined through contact-angle measurements. The results of the wettability 
investigation are presented in Fig. 2.  
The contact angle was measured on water and glycerol droplets. The initial PCL scaffolds were 
hydrophobic with a water and glycerol contact angle of 122.4 ± 3.7° and 129.4 ± 2.6°, respectively 
(Figs. 2 and Fig. S3). Immediately after the DC plasma treatment at 20, 45 and 75 W, the top side 
of the scaffold was fully wetted while the bottom side remained hydrophobic (Figs. 2 and Fig. S3). 
  
 
 
 
 
 
 
 
At the higher power (105 and 135 W), the bottom side became more hydrophilic: the contact angles 
of glycerol and water on the bottom sides were below 60° (Fig. S3). To demonstrate the differences 
in wettability of modified samples a highly viscous polar liquid, glycerol, was used. 
 
 
 
 
Fig. 2. Results of the wettability investigation. 
 
To investigate the wettability changes over time, the contact-angle measurements of the DC 
plasma-treated samples were repeated after 3 days, 7 days and 6 weeks (Figs. S4-S6). A 
hydrophobic recovery of plasma treated surface of PCL scaffold was observed. For instance, the 
contact angle on the top side of the samples treated with 20 and 45 W increased to 38.4° and 41.8°, 
respectively, after 3 days and to 103.5° and 83.2°, respectively, after one week. However, no 
significant changes appeared on the bottom sides (Figs. S4-S5). The hydrophobic recovery was 
retarded on samples treated at a higher power (Fig. S5). After 6 weeks, all plasma treated samples 
exhibited hydrophobic properties on both sides, and the contact angles increased towards their 
original values (Fig. S6).  
  
 
 
 
 
 
 
 
The HA immobilisation prevented hydrophobic recovery and the top side exhibited 
superhydrophilic properties throughout the study period (Figs. 2 and S7). As the treatment power 
increased, the bottom surface became more hydrophilic, as observed on plasma-treated scaffolds 
without additional modification. This effect is demonstrated in the video file in the Supplemental 
Data. 
Considering the wettability, morphological features and mechanical properties of the produced 
materials, 20W was determined as the most suitable discharge power for modifying the electrospun 
PCL vascular grafts by the DC plasma treatment. 
The effects of plasma treatment and HA immobilisation on the chemical composition and bonding 
states of the electrospun PCL vascular graft material were elucidated by XPS. Table 2 shows the 
atomic ratios and relative areas of the functional groups calculated by deconvoluting the C1s and 
N1s peaks. 
 
 
Table 2: Relative areas corresponding to the chemical bonds and atomic compositions of the 
investigated electrospun PCL vascular grafts. 
 
Sample 
Relative area corresponding to different chemical bonds, % Atomic ratio 
Carbon Nitrogen  
C1 C2 C3 C4 
 
NH2 
and/or 
H2NCO 
NH3+ 
C/O Ti/N 
BE (eV) 
285.0 ± 
0.2 
285.6 ± 
0.2 
286.5 ± 
0.2 
289.1 ± 0.2 399.9 ± 0.2 
402.5 ± 
0.2 
PCL lit.  
[22] 
52 17 17 14 - - - - 
Control 54 ± 2 16 ± 1 16 ± 1 14 ± 1 - - 3.17 - 
20 W top 
(fresh) 
56 ± 2 7 ± 1 20 ± 1 17 ± 1 71.7 28.3 1.33 2.17 
20 W top 
(6 weeks) 
55 ± 2 15 ± 1 14 ± 1 16 ± 1 68.0 32.0 1.08 2.91 
20 W 
bottom 
54 ± 2 16 ± 1 16 ± 1 14 ± 1 - - 3.15 - 
PCL-HA 
top 
53 ± 2 7 ± 1 23 ± 1 17 ± 1 77.2 22.8 1.21 2.92 
PCL-HA 
bottom 
54 ± 2 16 ± 1 16 ± 1 14 ± 1 - - 3.16 - 
 
The atomic constituents of the PCL vascular grafts give rise to unique spectral peaks in the 
photoelectron spectrum (e.g. the C1s peak), informing the bonding states of the PCL atoms. In the 
XPS survey spectrum of PCL vascular grafts peaks corresponding to C1s and O1s could be found. 
  
 
 
 
 
 
 
 
The C1s spectra of the control PCL vascular grafts were consistent with those reported in previous 
studies [19] [30] [31] (see Table 2 and Fig. 4).  
In the XPS survey spectrum of the fresh plasma treated PCL vascular grafts peaks corresponding 
to C1s, N1s, Ti2p and O1s could be found. The plasma treatment altered the shape of the C1s peak, 
increasing the C3 and C4 components and decreasing the C2 component. Peaks of amine and/or 
amide moieties (NH2, H2NC=O, 399.6 eV) and protonated/hydrogen bonded amine (NH3+, 402.3 
eV) [31] groups appear in the N1s spectra of the plasma-treated PCL vascular grafts (Fig. 3). 
Enhanced surface chemical bonding states related nitrogen functional groups were also confirmed 
by the surface chemical composition, in which Ti and N appeared after the plasma treatment (Table 
2). 
In the Ti2p spectrum of the plasma-treated PCL vascular grafts three components corresponding 
to TiO2 were observed: Ti2p1/2 at 464.2 eV, Ti2p3/2 at 458.3 eV, and satellite peak at 471.5 eV 
(Fig.4) [32]. The titanium chemical state is also confirmed by appearance of the TiO2 peak at 529.8 
eV in O1s spectrum (Fig. 5).  
The deposition of TiO2 instead of TiN after the plasma treatment could be explained by the 
following reasons. It is known that hydrophobic surfaces can adsorb water [33]. Considering the 
large surface of vascular grafts and low water desorption rate, even in vacuum [34] the titanium 
ions from the sputtering target could react with remaining water with the formation of TiO2. 
Standard Gibbs free energy of formation for TiO2 is -888.8 kJ/mol, whereas standard Gibbs free 
energy of formation for TiN is -243.8 kJ/mol [35]. Thus, the formation of TiO2 is 
thermodynamically favoured over TiN. 
The mechanism of the coating deposition on PCL-based grafts surface is probably similar to one 
described for polylactic acid [16]. The N2+ ions from plasma attack the PCL surface forming N∙ 
radicals and simultaneously breaking C-C, C-H and C-O bonds in PCL. The homolytic bond 
cleavage results in formation of various radical species on the polymer surface. These species can 
further react with nitrogen or residual water.  
Thus, the interaction with nitrogen would result in amine and amide groups as was found by XPS. 
The incorporation of oxygen originating from water could give ether [–C–O–C–] as well as 
hydroxyl moiety [–(C–OH)–]. Indeed, the XPS study showed increased C3 and C4 components 
and decreased C2 component in the C1s spectra of the plasma treated PCL grafts. The oxidation 
of amino groups generated on the PCL surface to oximes and amides can also proceed resulting in 
increased oxygen content on the PCL surface. 
  
 
 
 
 
 
 
 
After the plasma treatment, the polar side groups formed on the PCL grafts surface probably 
contributed to the hydrophilicity improvement of the scaffold, as observed in the contact-angle 
measurements (Fig. 2). The XPS spectra and elemental composition of the plasma treated PCL 
grafts bottom were like those of PCL control graft, indicating that modification did not occur on 
the other side (Table 2). 
In the plasma-treated PCL vascular graft stored for six weeks, the component intensities of the C1s 
peak differed from those of the freshly treated PCL graft and resembled those of the control graft. 
The C3 component was decreased and the C2 component was increased comparing to freshly 
treated PCL graft. In N1s spectra the intensity of the component corresponding to amine and/or 
amide moieties decreased, whereas the protonated amine component intensity increased (Table 2). 
Also, the decreased C/O ratio observed (Table 2).  
 
 
 
Fig. 4. C1s core-level spectra of the control PCL grafts (a); C1s core-level spectra (b), N1s core-
level spectra (c) and Ti2p core-level spectra of the PCL grafts immediately after treatment with 
magnetron DC plasma at 20 W. 
 
  
 
 
 
 
 
 
 
The changes in chemical bonding states and element content as well as hydrophobic recovery (Fig. 
2) of the scaffold surface after six weeks could be explained by the mechanisms of polymer 
“aging” described earlier in [36]. The increase in oxygen and nitrogen amount could be caused by 
the adsorption of contaminants like water from the atmosphere on the scaffolds surface during the 
sample storage. The other possible processes explaining the changes in elemental composition and 
wettability of the scaffold are sublimation or inward-diffusion of low molecular weight oxidized 
material appearing during plasma treatment, reorientation of the polar side groups of the 
macromolecules towards the subsurface region of the material, and outward diffusion of low 
molecular weight oligomers or additives [36].  
 
After HA immobilisation on the plasma treated PCL grafts surface, the intensity of the C3 
components of the C1s line increased (Table 2). The intensities of peaks corresponding to 
amine/amide moieties and protonated amino group (Table 2) increase and decrease, respectively. 
This can be explained by the presence of [–(C–OH)–], [–C–O–C–], and [-C(O)-N] moieties in the 
HA chemical structure and is consisted with previous reports [37]. The observed changes in surface 
chemical bonding states (Table 2) confirm HA immobilisation on the PCL surface. Comparing to 
O1s spectra of plasma treated PCL large high-energy component corresponding to several groups 
including amide (531.6 eV), ether (532.6 eV), hydroxy (532.9 eV), carbonyl (532.3 eV) and acetal 
(533.1 eV) increases in the O1s spectra of the PCL-HA graft (Fig. 4) [37,38].  
The largish proportion of polar groups in the HA structure contributed to the long-term 
superhydrophilicity of the PCL-HA surface (Fig. 2). 
 
  
 
 
 
 
 
 
 
  
Fig. 5. O1s core-level spectra of the control PCL grafts, PCL grafts immediately after treatment 
with magnetron DC plasma at 20 W and PCL-HA grafts.  
 
HA could bind to the PCL surface either covalently or by physical adsorption. It is known that if 
polymer is treated at vitreous state, the generated radicals and ions have reduced mobilities and 
can be trapped. Such trapped species could have a long lifetime. Thus, when a plasma treated graft 
was immersed in aqueous HA solution, the radicals remaining on its surface could interact with 
both water and HA resulting in covalent bonding of HA to PCL. However, the obtained data 
showed no strong evidences to support the described mechanism. On the other hand, partially 
protonated amino groups appear on the PCL surface after the plasma treatment. These groups can 
form a network of hydrogen bonding with hydroxy and carboxy groups of HA favouring HA 
physical adsorption on the graft surface. The elucidation of HA binding mechanism to plasma 
treated PCL graft surface is a complex issue that requires further additional studies. 
The XPS spectra and elemental composition of the PCL-HA grafts bottom were like those of PCL 
control scaffold, indicating that HA was not immobilized on the other side (Table 2). 
To assess the influence of plasma treatment and HA immobilisation on biological properties of the 
fabricated materials, we cultured human adipose-derived MSCs on the superhydrophilic and 
hydrophobic surfaces of the scaffold (Fig. 6) and evaluated the number of adhered cells and their 
morphology (Table 3).  
 
  
  
 
 
 
 
 
 
 
 
 
Table 3. Number of adhered MSCs on the sample surfaces, cells/mm2 
Sample Mean±SE 
Control 118.7±4.7 
PCL-HA bottom 160.6±6.9*, 
 
PCL-HA top 
200.6±7.1*,** 
 
* p<0.0001 comparing to control 
** p<0.05 comparing to PCL-HA bottom and PCL-HA top 
 
 
The fluorescence microscopy results have shown that all studied samples supported MSC 
attachment and growth in vitro. While some MSCs adhered to the surface of the material, the 
others started migrating into the bulk of the graft. On the control PCL sample as well as on the 
PCL-HA bottom sample isolated spindle-shaped cells were mostly found (Fig. 6). The number of 
MSCs on the surface of the PCL control scaffold was significantly lower compared to other 
samples (p <0.0001) (Table 3). It indicates a low functional activity of cells and a weak interaction 
of cells both among themselves and with the surface of untreated PCL graft [39]. The low 
functional activity of MSCs on the surface of PCL grafts without modification was previously 
observed in [40–42] due to the absence of chemically active functional groups on surface, which 
inhibit cell attachment, while the high hydrophobicity of polymer graft prevents the transport of 
dissolved nutrients and the removal of cell waste products. 
Plasma treatment of the outer surface of the PCL vascular graft and subsequent immobilization of 
HA increased the number of adherent cells on the outer surface (PCL-HA top) by more than 65% 
compared to the surface of the untreated sample (Table 3). MSCs cultured on PCL-HA top samples 
were connected via numerous cytoplasmic bridges forming syncytium (Fig. 6g-i). Improved cell 
adhesion to the surface of PCL-HA top samples is most likely caused by hydrophilicity of the 
scaffold surface due to introducing the oxygen- and nitrogen containing polar groups via plasma 
treatment with subsequent immobilisation of HA. It is known that HA mediates various cellular 
events in vivo including adhesion and morphogenesis, mainly though the interaction with the cell 
surface receptor CD44 [43]. On the other hand, the common shortcoming of HA-based tissue 
engineering scaffolds is poor cell adhesion [43] that can be circumvented by combining HA with 
  
 
 
 
 
 
 
 
adhesion stimulating molecules such as gelatin [44]. In our case, the observed improved cell 
adhesion to PCL-HA top can be attributed to the complex hybrid character of the coating that 
supports both cell binding through both CD44-HA interaction and amino-group presence. 
 
Fig. 6. Human adipose-derived MSCs stained on the surface of control PCL grafts (a-c), PCL 
grafts after immobilisation of HA (d-f) and PCL grafts after treatment with magnetron DC 
plasma at 20 W and immobilisation of HA (g-i). Vinculin is visualized in red (AlexaFluor 568 
goat anti-mouse IgG (H+L) anti-bodies), cell nuclei are visualized in blue (DAPI). 
Representative images taken at ×40 magnification are shown. 
 
 
The number of cells on the inner surface of the PCL of the vascular graft (PCL-HA bottom) is less 
than on the outer surface (PCL-HA top), but significantly higher than on the untreated graft (Table 
3). Probably, the reason for this is a low number of functional groups on the inner surface of the 
vascular graft and hydrophobicity, which prevents the immobilization of hyaluronic acid as well 
as cell adhesion. 
Improved cell adhesion, cells functional state and intercellular interaction observed in vitro on the 
outer surface of the modified graft (PCL-HA top), could result in increased endothelization rate 
  
 
 
 
 
 
 
 
from adventitia in vivo. Moreover, insignificant changes in the structure, mechanical properties 
and chemical composition of the luminal surface PCL of the graft will allow to maintain a low 
probability of blood clots inherent to grafts of this type [12,45,46]. 
 
4. Conclusions 
 
Thin porous PCL-based double-sided grafts were fabricated by DC plasma treatment with 
subsequent immobilisation of HA. The plasma treatment changed the surface wettability of the 
PCL-based scaffolds from hydrophobic to superhydrophilic. However, after six weeks, the surface 
restored its hydrophobicity. The immobilised HA not only conferred high biocompatibility, but 
also stabilised the superhydrophilic surface against hydrophobic recovery. 
The proposed modification does not significantly affect the mechanical properties of the 
electrospun PCL grafts. The fabricated scaffolds with a hydrophilic outer surface that ensures 
proper endothelization and hydrophobic inner surface that prevents early loss of mechanical 
integrity and lead to gradient of wettability and degradation rate. Plasma scaffold surface 
modification followed by immobilization of hyaluronic acid improves cell adhesion. 
Overall, the use of DC magnetron plasma with appropriate modification parameters and 
subsequent HA immobilisation is a simple and scalable method for producing thin double-sided 
PCL vascular grafts with on hydrophilic and one hydrophobic side. This approach can potentially 
be used for modification of grafts from biodegradable polymers such as PCL, PLA, PGA and their 
copolymers and blends. 
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